1. Home
  2. CIVB vs CKPT Comparison

CIVB vs CKPT Comparison

Compare CIVB & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIVB
  • CKPT
  • Stock Information
  • Founded
  • CIVB 1884
  • CKPT 2014
  • Country
  • CIVB United States
  • CKPT United States
  • Employees
  • CIVB N/A
  • CKPT N/A
  • Industry
  • CIVB Major Banks
  • CKPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIVB Finance
  • CKPT Health Care
  • Exchange
  • CIVB Nasdaq
  • CKPT Nasdaq
  • Market Cap
  • CIVB 305.3M
  • CKPT 335.9M
  • IPO Year
  • CIVB N/A
  • CKPT 2017
  • Fundamental
  • Price
  • CIVB $19.93
  • CKPT $4.04
  • Analyst Decision
  • CIVB Buy
  • CKPT Buy
  • Analyst Count
  • CIVB 4
  • CKPT 3
  • Target Price
  • CIVB $22.67
  • CKPT $4.33
  • AVG Volume (30 Days)
  • CIVB 41.6K
  • CKPT 1.7M
  • Earning Date
  • CIVB 04-24-2025
  • CKPT 05-09-2025
  • Dividend Yield
  • CIVB 3.43%
  • CKPT N/A
  • EPS Growth
  • CIVB N/A
  • CKPT N/A
  • EPS
  • CIVB 2.01
  • CKPT N/A
  • Revenue
  • CIVB $149,094,000.00
  • CKPT $41,000.00
  • Revenue This Year
  • CIVB $15.59
  • CKPT $102,182.93
  • Revenue Next Year
  • CIVB $5.38
  • CKPT $351.71
  • P/E Ratio
  • CIVB $9.88
  • CKPT N/A
  • Revenue Growth
  • CIVB N/A
  • CKPT N/A
  • 52 Week Low
  • CIVB $13.60
  • CKPT $1.38
  • 52 Week High
  • CIVB $23.70
  • CKPT $4.50
  • Technical
  • Relative Strength Index (RSI)
  • CIVB 54.67
  • CKPT 63.60
  • Support Level
  • CIVB $18.80
  • CKPT $3.94
  • Resistance Level
  • CIVB $20.08
  • CKPT $4.06
  • Average True Range (ATR)
  • CIVB 0.97
  • CKPT 0.04
  • MACD
  • CIVB 0.13
  • CKPT -0.03
  • Stochastic Oscillator
  • CIVB 86.01
  • CKPT 83.33

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Share on Social Networks: